Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Receivables - Net (2016 - 2023)

Historic Receivables - Net for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2023 value amounting to $3.5 million.

  • Abeona Therapeutics' Receivables - Net rose 8726.59% to $3.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $3.5 million, marking a year-over-year increase of 8726.59%. This contributed to the annual value of $3.0 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Abeona Therapeutics reported Receivables - Net of $3.5 million as of Q2 2023, which was up 8726.59% from $1.0 million recorded in Q3 2022.
  • In the past 5 years, Abeona Therapeutics' Receivables - Net ranged from a high of $7.0 million in Q3 2020 and a low of $15000.0 during Q3 2019
  • In the last 5 years, Abeona Therapeutics' Receivables - Net had a median value of $1.5 million in 2022 and averaged $2.1 million.
  • In the last 5 years, Abeona Therapeutics' Receivables - Net crashed by 9972.56% in 2019 and then skyrocketed by 4656666.67% in 2020.
  • Abeona Therapeutics' Receivables - Net (Quarter) stood at $15000.0 in 2019, then soared by 46566.67% to $7.0 million in 2020, then plummeted by 57.14% to $3.0 million in 2021, then crashed by 65.1% to $1.0 million in 2022, then soared by 234.29% to $3.5 million in 2023.
  • Its last three reported values are $3.5 million in Q2 2023, $1.0 million for Q3 2022, and $1.9 million during Q2 2022.